In regard to CD19-positive relapse, whose key mechanism lies in poor persistence of CAR T-cells, CD19 is still present on the surface of B-ALL cells and can be detected by flow cytometry (17). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.